We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$54.2B
AUM Growth
-$1.5B
Cap. Flow
-$2.46B
Cap. Flow %
-4.53%
Top 10 Hldgs %
9.23%
Holding
3,766
New
402
Increased
1,315
Reduced
1,324
Closed
445

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$549M
2
CVS icon
CVS Health
CVS
+$537M
3
META icon
Meta Platforms (Facebook)
META
+$515M
4
MCD icon
McDonald's
MCD
+$386M
5
HD icon
Home Depot
HD
+$308M

Sector Composition

Rank Sector Weight
1 Healthcare 11.4%
2 Consumer Discretionary 10.14%
3 Technology 10.06%
4 Financials 9.8%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRX
3276
DELISTED
Catalyst Pharmaceutical
CPRX
$23K ﹤0.01%
33,094
-415,239
-93% -$334K
PAACW
3277
DELISTED
Pacific Special Acquisition Corp. Warrants
PAACW
$20K ﹤0.01%
195,000
CJES
3278
DELISTED
C&J ENERGY SVCS LTD
CJES
$20K ﹤0.01%
33,582
-631,015
-95% -$588K
GOGL
3279
DELISTED
Golden Ocean Group
GOGL
$19K ﹤0.01%
5,582
-6,108
-52% -$23.2K
NM
3280
DELISTED
Navios Maritime Holdings Inc.
NM
$16K ﹤0.01%
+1,967
New +$20.8K
GST
3281
DELISTED
Gastar Exploration Inc.
GST
$16K ﹤0.01%
14,111
-4,200
-23% -$4.95K
ANDAW
3282
DELISTED
Andina Acquisition Corp. II Warrant
ANDAW
$16K ﹤0.01%
+194,900
New +$19.9K
PTX
3283
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$15K ﹤0.01%
3,400
-13,911
-80% -$90.8K
UEC icon
3284
Uranium Energy
UEC
$4.71B
$11K ﹤0.01%
12,875
TPLM
3285
DELISTED
Triangle Petroleum Corporation
TPLM
$9K ﹤0.01%
32,966
-311,473
-90% -$118K
LSTA icon
3286
Lisata Therapeutics
LSTA
$15.2M
$8K ﹤0.01%
91
-243
-73% -$22.4K
CTIC
3287
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5K ﹤0.01%
+1,326
New +$6.08K
RXII
3288
DELISTED
GALENA BIOPHARMA INC COM
RXII
$5K ﹤0.01%
10,097
-196,846
-95% -$97.5K
ACHV icon
3289
Achieve Life Sciences
ACHV
$626M
-6
Closed -$9K
ADC icon
3290
Agree Realty
ADC
$9.68B
-13,374
Closed -$514K
ADM icon
3291
CALL
Archer Daniels Midland
ADM
$41.4B
-29,700
Closed -$1.08M
ADM icon
3292
PUT
Archer Daniels Midland
ADM
$41.4B
-65,700
Closed -$2.39M
AGEN
3293
Agenus
AGEN
$249M
-4,403
Closed -$359K
AGIO icon
3294
Agios Pharmaceuticals
AGIO
$2.16B
-7,227
Closed -$293K
AL
3295
CALL
DELISTED
Air Lease Corp
AL
-30,000
Closed -$964K
AMG icon
3296
CALL
Affiliated Managers Group
AMG
$9.46B
-37,200
Closed -$6.04M
ANET icon
3297
Arista Networks
ANET
$219B
-343,200
Closed -$1.35M
ARE icon
3298
Alexandria Real Estate Equities
ARE
$8.88B
-8,409
Closed -$764K
ASMB icon
3299
Assembly Biosciences
ASMB
$506M
-2,077
Closed -$125K
ATI icon
3300
PUT
ATI
ATI
$27B
-177,600
Closed -$2.9M

Similar funds

D.E. Shaw & Co's Q2 2016 Portfolio in Review

As of Q2 2016, D.E. Shaw & Co held 3,766 positions worth $54.2B, down 2.7% from $55.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $2.46B in Q2 2016, closing 445 positions and reducing 1,324 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $369M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, D.E. Shaw & Co opened a new position in Liberty Media Corporation Series C Liberty SiriusXM Common Stock worth $198M.

  • D.E. Shaw & Co's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 8,430,023 shares worth $198M.
  • D.E. Shaw & Co added most to Amazon in Q2 2016, an estimated $549M increase.
  • D.E. Shaw & Co's biggest Q2 2016 reduction was Booking.com, cutting an estimated $475M.
  • D.E. Shaw & Co fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $369M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $54.2B portfolio in Q2 2016.
  • D.E. Shaw & Co opened 402 new positions and closed 445 in Q2 2016.
  • D.E. Shaw & Co's portfolio value fell 2.7% quarter-over-quarter to $54.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.